dog

“Meowtel: The Feline-Focused Enterprise That Pounced Through Financial Challenges and Achieved Profitability”

Ceo Sonya Petcavich
Dogs are the most popular pet in the U.S.: 65.1 million households have one, according to the American Pet Products Association. Sonya Petcavich, the founder of cat-sitting app Meowtel, thinks that cats, and cat people, deserve more. “Rover had been around for a few years, and Wag was picking up steam, but they were so dog focused. Meowtel has made it to this point raising just under $1 million in venture capital. ImpriMed, a dog oncology startup, raised $23 million in November, and Fi, a smart dog collar, has raised more than $40 million in venture capital.

Xiaomi’s Newest Robo-Pooch Perform Parkour Tricks and Carries a Price Tag of $3,000

71e6aad5 350a 438a 9aab Fee7e7ea2f6b
When it was first unveiled in the summer of 2021, Xiaomi’s CyberDog designed was best described as a more nightmarish version of Boston Dynamics’ Spot. Announced this past summer, CyberDog 2 looks a bit more friendly than its predecessor. The robot dog is still no Sony Aibo. Watching it do its little dance really did remind me of a scaled down version of Boston Dynamics’ familiar robot. The above video also suggests that the robot dog might one day replace the real thing, owing to its ability to speak back.

“Cooking for Your Four-Legged Companion: Simplified with ChefPaw’s Healthy Recipes”

20230109 Dsc00242
ChefPaw is an machine designed to prepare homemade dog food. The appliance aims to provide an alternative to store-bought dog food, focusing on fresh ingredients tailored to individual pet dietary needs – and saving a ton of money along the way. It turns out that fresh-ingredient food for your four-legged furbaby is hella expensive, and ChefPaw wants to make it easier to make your own. ChefPaw operates by adding fresh ingredients into the machine, which then mixes and cooks the food at lower temperatures, a process taking approximately 40 minutes. The machine can roughly chop the food to take the shape of usual dog food, or blend it more smoothly for pets that have difficulties eating after surgery, for example.

“Introducing Invoxia’s innovative smart collar for feline and canine companions”

Invoxia Minitailz
And Invoxia is going all out by releasing a new smart collar called Invoxia Minitailz that is suitable for both cats and dogs. The company said that this gadget is an upgrade from last year’s Invoxia Smart Dog Collar, which measured both location and biometrics like the heart rate of your dog. The Minitailz just weighs around 36 grams as compared to last year’s Smart Dog Collar which weighed at 130g. Plus, it can be fitted to almost any existing cat or dog collar through an adjustable ring. Invoxia’s Minitailz smart pet tracker for dogs goes on sale today and the cat version will be available in March 2024.

“Top 5 Futuristic Pet Tech Presents to Spoil Your Adorable Furry Friends in 2023”

Pet Holiday Gifts
But, when used occasionally, Cheerble and other smart toys are a great time-consuming activity. However, the Fi Smart Dog Collar offers more than just peace of mind. The Fi Smart Dog Collar creates a geofence for your dog and uses algorithms to detect when your dog escapes and send alerts to the app. Petlibro’s pet water fountain is designed to entice cats to embrace their ancestral background, with its quiet, flowing stream and filtered H2O — though it’s a little more luxurious than drinking straight from a river. However, PetLibro says the filter keeps the water clear of pet fur and saliva, so you might want to comply with the company’s guidance.

“Expanding AI Technology in Human Oncology: The Mission of ImpriMed, a Revolutionary Dog Cancer Treatment”

Gettyimages 1397710182
ImpriMed, a California-based precision medicine startup, builds AI-powered dog cancer treatment technology that helps veterinarians identify the most suitable drugs for individual canine and feline blood cancers. The startup, which centers on improving treatment outcomes of dogs and cats with cancer first, now aims to expand its precision medicine technology for human oncology applications. “Also, the proven know-how acquired from developing AI algorithms in veterinary oncology streamlines the building of new predictive models in human oncology. For human precision oncology, its AI software for multiple myeloma, a rare blood cancer, is in the process of approval, aiming to commercialize in 2025, Lim told TechCrunch. ImpriMed’s unique strength is “the ability to develop and incorporate AI models into the personalized medicine service workflow,” according to Lim.